All fields are required.

Close Appointment form
UKAS Accredited for N-terminal protein sequencing

Oct 12, 2015 by Marion Peak

Introducing Protein Sequencing from AltaBioscience AltaBioscience is accredited by UKAS for N-terminal protein sequencing and amino acid analysis. UKAS accreditation positions AltaBioscience alongside the few laboratories world-wide working to such demanding standards of quality assurance. Otherwise known as Edman degradation, [...]

More Info
Quality Standards Update

May 27, 2014 by Marion Peak

AltaBioscience is pleased to announce that we have once again retained our on-going conformity to 2 quality standards, ISO 17025: 2005 and ISO 9001:2008. A recent ISO 17025: 2005 audit by UKAS for technical competence in amino acid analysis and [...]

More Info
ISO accreditation reaffirmed

Apr 16, 2013 by Marion Peak

ISO 9001 certification and ISO 17025 accreditation reaffirmed We are delighted to announce the renewed affirmation of two internationally recognised quality standards. Our ISO 17025 accreditation for protein sequencing and amino acid analysis demonstrates that we meet both the regulatory [...]

More Info
Innovation Award for Life Sciences

Nov 16, 2012 by Marion Peak

Groundbreaking life sciences collaboration wins innovation award (Lord Stafford Awards) A joint venture company between Abingdon Health and the University of Birmingham won ‘The Open Collaboration Award’ at the Lord Stafford Awards ceremony and dinner last night. The primary objective of [...]

More Info
Alta Bioscience wins £100,000 grant from the Birmingham Post Business Growth Fund

Sep 17, 2012 by Marion Peak

Alta Bioscience Ltd (“Alta Bioscience” or “the Company”), a specialist contract manufacturing and analysis organization, is pleased to announce that it has won funding of £100,000 in the form of a grant from the Birmingham Post Business Growth Fund, which [...]

More Info
Abingdon Health and University of Birmingham to invest £2 million in Joint Venture

Jul 04, 2012 by Marion Peak

Bioscience Ventures Ltd is commercialising IP from the UOB Abingdon Health Ltd (“Abingdon” or “the Company”), a specialist medical diagnostics company, and the University of Birmingham announce that they have each committed £1 million of investment into their joint venture, [...]

More Info
University of Birmingham scientists develop urine test for cancer

Sep 15, 2011 by Marion Peak

Scientists at the University of Birmingham have developed a ground-breaking technique that uses a urine test to help to diagnose adrenal cancer. The test, which enables endocrinologists to distinguish between harmless and cancerous tumours, uses a biomarker tool to measure [...]

More Info

© 2020 AltaBioscience